Choosing the right option for renal-cell carcinoma

Lancet Oncol. 2012 Oct;13(10):970-1. doi: 10.1016/S1470-2045(12)70393-5. Epub 2012 Sep 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Phenylurea Compounds / therapeutic use*
  • Pyridines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Pyridines
  • regorafenib